<html>
<link rel="stylesheet" href="../datatable/css/demo_page.css" type="text/css" id=""/>
<link rel="stylesheet" href="../datatable/css/demo_table.css" type="text/css" id=""/>
<link rel="stylesheet" href="../style.css" type="text/css" id=""/>
<script type="text/javascript" src="http://code.jquery.com/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="../datatable/js/jquery.dataTables.js"></script>
<!-- Google Analytics -->
<script>
 (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
 (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
 m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
 })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

 ga('create', 'UA-43872538-6', 'osehra.org');
 ga('send', 'pageview');
</script>


<script type="text/javascript" id="js">
  $(document).ready(function() {
  // call the tablesorter plugin
      $("#NTAuNjA1LTY5").dataTable({
        "bPaginate": false,
        "bLengthChange": false,
        "bInfo": false,
        "bStateSave": true,
        "bSort": false
      });
}); </script>

<body id="dt_example"><div id="container" style="width:80%"><h1>CN000 (69) &nbsp;&nbsp;  VA DRUG CLASS (50.605)</h1>
<div id="demo"><table id="NTAuNjA1LTY5" class="display">
<thead>
<tr>
<th>Name</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>CODE</td>
<td>CN000</td>
</tr>
<tr>
<td>CLASSIFICATION</td>
<td>CENTRAL NERVOUS SYSTEM MEDICATIONS</td>
</tr>
<tr>
<td>TYPE</td>
<td>MAJOR</td>
</tr>
<tr>
<td>DESCRIPTION</td>
<td><pre>
NOTE: Includes all single-entity and combination analgesic
       products containing an opioid agonist or partial
       agonist (CN101); non-opioid single-entity and combination
       analgesic products containing acetaminophen and/or
       salicylates (CN103); single-entity monocyclic,
       bicyclic, or tetracyclic antidepressants (CN609); and
       single-entity products containing a phenothiazine or
       thioxanthene (CN701).
      Excludes antitussive products containing an agonist or
       partial agonist opioid (RE301); antidiarrheal products
       containing tincture of opium or paregoric (GA400); single-
       entity anticholinergic products and dopamine agonists
       (AU350); pargyline (CV490); procarbazine (AN900);
       anesthetics, local topical (DE700).
</pre>
</td>
</tr>
<tr>
<td>MASTER ENTRY FOR VUID</td>
<td>YES</td>
</tr>
<tr>
<td>VUID</td>
<td>4021579</td>
</tr>
<tr>
<td>EFFECTIVE DATE/TIME</td>
<td>
<ol>
<li>
<dt>EFFECTIVE DATE/TIME:  &nbsp;&nbsp;2005-03-10 00:00:00</dt>
<dt>STATUS:  &nbsp;&nbsp;ACTIVE</dt>
</li>
</ol>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</body></html>